EUCTR2014-001097-34-GR进行中（未招募）1 期
A Phase 2 Randomised, Double-blind, Placebo-controlled,Single-dose, Dose-ranging Study of the Efficacy andSafety of MEDI4893, a Human Monoclonal AntibodyAgainst Staphylococcus aureus Alpha Toxin inMechanically Ventilated Adult Subjects - SAATELLITE
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 462
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Colonized with S aureus , expected to require prolonged intubation and mechanical ventilation, without any evidence of active pneumonia.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 231
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 231
排除标准
- •Staphylococcal disease at randomisation; lung injury score consistent with pneumonia; current lung disease; chronic tracheostomy patients; currently receiving systemic anti-staphylococcal antibiotics; moribund patients.
研究者
相似试验
进行中（未招募）
不适用
A Phase 2 Randomised, Double-blind, Placebo-controlled Study of the Effects of VIA-2291, a 5-lipoxygenase Inhibitor, on Atherosclerotic Plaque and Biomarkers of Vascular Inflammation in Patients with Carotid Stenosis Undergoing Elective Carotid Endarterectomy. - VIA-2291-02EUCTR2006-001635-21-ITVIA PHARMACEUTICALS, INC.80
进行中（未招募）
1 期
Clinical trial looking at safety and efficacy of MEDI4893 in prevention of pneumonia caused by bacterial infection with Staphylococcus aureus in high-risk patients.Prevention of Staphyloccus aureus pneumoniaMedDRA version: 17.0Level: LLTClassification code 10041942Term: Staphylococcus aureus pneumoniaSystem Organ Class: 100000004862EUCTR2014-001097-34-BEMedImmune, LLC213
进行中（未招募）
1 期
Clinical trial looking at safety and efficacy of MEDI4893 in prevention of pneumonia caused by bacterial infection with Staphylococcus aureus in high-risk patients.EUCTR2014-001097-34-IEMedImmune, LLC213
进行中（未招募）
1 期
Clinical trial looking at safety and efficacy of MEDI4893 in prevention of pneumonia caused by bacterial infection with Staphylococcus aureus in high-risk patients.Prevention of Staphyloccus aureus pneumoniaMedDRA version: 18.1Level: LLTClassification code 10041942Term: Staphylococcus aureus pneumoniaSystem Organ Class: 100000004862EUCTR2014-001097-34-HUMedImmune, LLC462
进行中（未招募）
1 期
Clinical trial looking at safety and efficacy of MEDI4893 in prevention of pneumonia caused by bacterial infection with Staphylococcus aureus in high-risk patients.EUCTR2014-001097-34-PTMedImmune, LLC213